OraSure Technologies (OSUR) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

OSUR OraSure Technologies

Watchlist

3.580
-0.040-1.10%

Close Dec 30 16:00 ET

3.580
0.0000.00%

Post 20:01 ET

267.05MMarket Cap23.87P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

OSUR Stock Rises Following the Acquisition of Sherlock Biosciences
Zacks Dec 26 10:35 ET
Express News | OraSure Technologies Inc - Sherlock's Ct/Ng Self-Test Expected to Be Submitted to FDA by End of 2025
ReutersDec 19 16:02 ET
Press Release: OraSure Technologies Acquires Sherlock Biosciences
Dow JonesDec 19 16:02 ET
Express News | OraSure Technologies Acquires Sherlock Biosciences
ReutersDec 19 16:02 ET
OraSure Secures $7.5M Contract With $11M Potential for Marburg Virus Rapid Test Development
BenzingaDec 2 07:16 ET
Express News | OraSure Technologies : Initial Contract Award, Valued at About $7.5 Mln Over Multiple Years in Base Period With Potential Value up to $11 Mln
ReutersDec 2 07:05 ET

Comments

Jaguar8

Dec 19 15:02

NEWS

$OraSure Technologies (OSUR.US)$
OraSure Technologies Acquires Sherlock Biosciences
Thursday, 19th December at 4:02 pm
BETHLEHEM, Pa., Dec. 19, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. ("OTI") (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced the acquisition of Sherlock Biosciences, Inc., a global health company bringing next-generation diagnostics to consumers and healthcare providers.
This acquisition expands OraS...

Tonyco

Dec 2 22:02

$OraSure Technologies (OSUR.US)$
Take a look. See if you like it.

Jaguar8

Dec 2 06:26

NEWS

$OraSure Technologies (OSUR.US)$
OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test
OraSure Technologies (NASDAQ: OSUR) has received a federal contract through the Rapid Response Partnership Vehicle (RRPV) to develop a Marburg Virus Disease (MVD) rapid antigen test. The initial contract is valued at $7.5 million over multiple years, with potential value up to $11 million. The funding from BARDA aims to achieve FDA 510(k) clearance for a single-use lateral f...

Moomoo AI

Feb 29 06:13

The consistent ROCE and increase in capital employed suggest that OraSure Technologies is not investing in high return investments. The underlying trends do not inspire confidence in the potential for the company to become a multi-bagger in the future.

Here's What To Make Of OraSure Technologies' (NASDAQ:OSUR) Decelerating Rates Of Return

Moomoo AI

Dec 20, 2023 06:41

The low P/S ratio is ascribed to investors predicting the strong revenue growth will falter. The foreseen revenue decline justifies the low ratio. Without significant changes, a sharp stock price increase seems improbable.